CD79A and cancer: GSVA analysis also confirmed that the high SNGC-expressed subgroups were significantly enriched in various cancer- and immune-associated pathways, such as mismatch repair, DNA replication, and intestinal immune network for IgA production pathways (Figure 4B), indicating that the activation of SNCG might participate in modulating cancer and immune progression.